Gentian Diagnostics ASA (FRA:6FK)

Germany flag Germany · Delayed Price · Currency is EUR
4.790
+0.180 (3.90%)
Last updated: Dec 10, 2025, 9:14 AM CET
46.93%
Market Cap74.52M
Revenue (ttm)14.72M
Net Income (ttm)3.65M
Shares Outn/a
EPS (ttm)0.23
PE Ratio20.42
Forward PE55.33
Dividend0.03 (0.72%)
Ex-Dividend DateMay 7, 2025
Volumen/a
Average Volumen/a
Open4.790
Previous Close4.610
Day's Range4.790 - 4.790
52-Week Range3.200 - 5.420
Betan/a
RSI55.78
Earnings DateFeb 11, 2026

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2001
Employees 63
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 6FK
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.